1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Deciphering the epigenetic programming underlying CD8 T cell dysfunction in solid tumors
    Meeting Abstract

    Philip, M.; Fairchild, L.; Sun, L.; Viale, A.; Leslie, C.; Schietinger, A.
    Journal of Immunology (2016)

    Fulltext@MSK | Save
  • MiR-23~27~24 clusters control effector T cell differentiation and function
    Meeting Abstract

    Lu, L. F.; Cho, S.; Wu, C. J.; Yasuda, T.; Cruz, L. O.; Khan, A. A.; Lin, L. L.; Nguyen, D. T.; Miller, M.; Lee, H. M.; more...
    Journal of Immunology (2016)

    Fulltext@MSK | Save
  • Human natural killer cell education is dynamically controlled by environmental and cell-intrinsic HLA
    Meeting Abstract

    Boudreau, J.; Liu, X. R.; Zhao, Z.; Zhang, A.; Shultz, L. D.; Greiner, D. L.; Dupont, B.; Hsu, K. C.
    Journal of Immunology (2016)

    Fulltext@MSK | Save
  • Impact of disease burden on long-term outcome of CD19-targeted CAR modified T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Sadelain, M.; Brentjens, R.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Integrative genomics identifies the molecular basis of resistance to Azacitidine therapy in Myelodysplastic Syndromes
    Meeting Abstract

    Unnikrishnan, A.; Papaemmanuil, E.; Beck, D.; Verma, A.; Kumari, A.; Woll, P.; Richards, L.; Knezevic, K.; Chandrakanthan, V.; Thoms, J.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
    Meeting Abstract

    Manders, P.; Joshua, A. M.; Kefford, R.; Robert, C.; Ribas, A.; Hamid, O.; Daud, A.; Wolchok, J. D.; Hwu, W. J.; Weber, J. S.; more...
    Asia-Pacific Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Metabolic control of asyMYCtric division
    Journal Article

    Do, M. H.; Li, M. O.
    Cell Research (2016)

    Fulltext@MSK | Save
  • Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition
    Journal Article

    Gao, P.; Yang, H.; Rajashankar, K. R.; Huang, Z. W.; Patel, D. J.
    Cell Research (2016)

    Fulltext@MSK | Save
  • Ga-68 DOTATOC PET/CT-guided biopsy and cryoablation with autoradiography of biopsy specimen for treatment of tumor-induced osteomalacia
    Journal Article

    Maybody, M.; Grewal, R. K.; Healey, J. H.; Antonescu, C. R.; Fanchon, L.; Hwang, S.; Carrasquillo, J. A.; Kirov, A.; Farooki, A.
    CardioVascular and Interventional Radiology (2016)

    Fulltext@MSK | Save
  • Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: Overall survival and updated progression-free survival results from a phase II study
    Journal Article

    Smyth, L. M.; Iyengar, N. M.; Chen, M. F.; Popper, S. M.; Patil, S.; Wasserheit-Lieblich, C.; Argolo, D. F.; Singh, J. C.; Chandarlapaty, S.; Sugarman, S. M.; more...
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save